pharmacological imaging
Showing 1 - 25 of >10,000
MDD Trial in Vienna (Ketamine, Placebo)
Recruiting
- Major Depressive Disorder
- Ketamine
- Placebo
-
Vienna, AustriaMedical University of Vienna
Jul 14, 2022
Coronary Artery Disease Trial in Aarhus N ([O-15]-Water PET Myocardial Perfusion Imaging (MPI))
Recruiting
- Coronary Artery Disease
- [O-15]-Water PET Myocardial Perfusion Imaging (MPI)
-
Aarhus N, DenmarkAarhus University Hospital
Jun 10, 2022
Adenocarcinoma of the Prostate, Stage IIB Prostate Cancer, Stage III Prostate Cancer Trial in Duarte (biological, procedure,
Active, not recruiting
- Adenocarcinoma of the Prostate
- +3 more
- anti-PSMA monoclonal antibody MDX1201-A488
- +5 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 17, 2022
Recurrent Plasma Cell Myeloma, Plasma Cell Myeloma, Secondary Amyloidosis Trial in Duarte (biological, drug, procedure, other)
Active, not recruiting
- Recurrent Plasma Cell Myeloma
- +2 more
- Daratumumab
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 22, 2022
Neuro-Degenerative Disease, Cancer Trial in New York (Clonidine Pill)
Terminated
- Neuro-Degenerative Disease
- Cancer
- Clonidine Pill
-
New York, New YorkWeill Cornell Medicine
Jun 21, 2021
Breast Cancer, Colon Cancer, Extrahepatic Bile Duct Cancer Trial in Duarte (procedure, other, drug)
Active, not recruiting
- Breast Cancer
- +11 more
- radionuclide imaging
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Oct 20, 2022
Colorectal Cancer, Metastatic Colorectal Cancer, RAS Wild Type Colorectal Cancer Trial in Nashville (drug, biological, other,
Recruiting
- Colorectal Cancer
- +3 more
- Glutaminase Inhibitor CB-839
- +5 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Mar 29, 2022
Cardiovascular Disease, Atherosclerosis, Coronary Artery Disease Trial in Houston (Comprehensive therapy program for risk factor
Active, not recruiting
- Cardiovascular Disease
- +3 more
- Comprehensive therapy program for risk factor modification
-
Houston, TexasWeatherhead PET Center, Memorial Hermann Hospital TMC
May 20, 2022
Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States
Active, not recruiting
- Clear Cell Renal Cell Carcinoma
- +3 more
- Aldesleukin
- +6 more
-
Los Angeles, California
- +3 more
Nov 16, 2022
Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Detroit (drug, radiation,
Completed
- Adenocarcinoma of the Prostate
- +3 more
- cabozantinib-s-malate
- +4 more
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Aug 3, 2021
Advanced Cervical Adenocarcinoma, Advanced Cervical Adenosquamous Carcinoma, Advanced Cervical Squamous Cell Carcinoma Trial in
Recruiting
- Advanced Cervical Adenocarcinoma
- +12 more
- Biospecimen Collection
- +11 more
-
Los Angeles, California
- +15 more
Aug 23, 2022
MDD Trial (Ketamine Hydrochloride, Esketamine, Placebo)
Not yet recruiting
- Major Depressive Disorder
- Ketamine Hydrochloride
- +2 more
- (no location specified)
Oct 8, 2020
Cognitive Impairment Trial in New Haven (MRI, Ketamine)
Completed
- Cognitive Impairment
- MRI
- Ketamine
-
New Haven, ConnecticutMagnetic Resonance Research Center
Jun 29, 2020
Myelodysplastic Syndrome, Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Myeloid Leukemia Trial in
Recruiting
- Myelodysplastic Syndrome
- +16 more
- Computed Tomography
- +6 more
-
Scottsdale, Arizona
- +2 more
Feb 3, 2022
Lumbar Disc Herniation Trial in Korea, Republic of (non-pharmacological treatment strategy, pharmacological treatment strategy)
Recruiting
- Lumbar Disc Herniation
- non-pharmacological treatment strategy
- pharmacological treatment strategy
-
Seoul, Gangnam-Gu, Korea, Republic of
- +3 more
Aug 29, 2023
Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in
Recruiting
- Advanced Malignant Solid Neoplasm
- +44 more
- Biopsy
- +23 more
-
Birmingham, Alabama
- +166 more
Feb 2, 2023
ADHD, Executive Dysfunction Trial (Goal Management training)
Not yet recruiting
- Attention Deficit Hyperactivity Disorder
- Executive Dysfunction
- Goal Management training
- (no location specified)
May 26, 2023
Vestibular Migraine Trial in Kuala Lumpur (Lifestyle modifications, Vestibular rehabilitation exercise)
Not yet recruiting
- Vestibular Migraine
- Lifestyle modifications
- Vestibular rehabilitation exercise
-
Kuala Lumpur, MalaysiaUniversiti Malaya Medical Centre
Jun 19, 2023
Schizophrenia Trial in Bangalore (oxytocin)
Completed
- Schizophrenia
-
Bangalore, Karnataka, IndiaNational Institute of Mental Health and Neurosciences
Nov 6, 2019
Coronary Artery Disease (CAD) Trial in Worldwide (PET MPI, SPECT MPI, Pharmacological stress agents)
Completed
- Coronary Artery Disease (CAD)
- PET MPI
- +2 more
-
Birmingham, Alabama
- +52 more
May 18, 2022
Diabetic Peripheral Neuropathy Trial (Non-pharmacological Heat, Pressure, and Vibration)
Not yet recruiting
- Diabetic Peripheral Neuropathy
- Non-pharmacological Heat, Pressure, and Vibration
- (no location specified)
Jan 31, 2023
Fibromyalgia, Hyperbaric Oxygen Trial in Zerifin (Hyperbaric oxygen therapy, Cymbalta / lyrica, Crossover Hyperbaric oxygen
Completed
- Fibromyalgia
- Hyperbaric Oxygen
- Hyperbaric oxygen therapy
- +2 more
-
Zerifin, IsraelAssaf-Harofeh Medical Center
Jul 6, 2022
Seeks to Understand Clinical, Genomic, Pharmacological,
Not yet recruiting
- Purine-Pyrimidine Metabolism
- Metabolic Disease
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 26, 2023
Schizophrenia; Psychosis Trial in Nashville (Levetiracetam (LEV) 500 mg, Placebo)
Recruiting
- Schizophrenia; Psychosis
- Levetiracetam (LEV) 500 mg
- Placebo
-
Nashville, TennesseeVanderbilt University Medical Center
Mar 15, 2022
Bipolar Disorder Trial in Leiden (lithium MRSI)
Not yet recruiting
- Bipolar Disorder
- lithium MRSI
-
Leiden, Zuid Holland, NetherlandsLeiden University Medical Center
Nov 15, 2023